Clinical Trial Update: Vescell(TM) for the Treatment of Patients With Severe Anginal Syndrome With or Without Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

This entry notes a Phase 1/2 clinical trial evaluating Vescell for severe anginal syndrome with or without heart failure, with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Heart Failure

Drugs mentioned

• Vescell

Snippet

Sponsor: TheraVitae Ltd. | Conditions: Angina Pectoris | Phase 1, Phase 2 | Status: UNKNOWN